ACXP · Acurx Pharmaceuticals, Inc. · Fails to Deliver
$0.99
-0.05 (-4.37%)
At close · Nov 12
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, our independent registered public accounting firm has expressed substantial doubt about our ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.”View the 10-Q filed Aug 13, 2026
Market Cap
$5.97M
Shares
6.06M
Volume · Nov 12
159.19K
Avg daily vol (3M)
124.59K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-10-14 | 1,212 | $1.20 | $1,454 |
| 2026-10-13 | 3,944 | $1.28 | $5,048 |
| 2026-10-09 | 3,697 | $1.25 | $4,621 |
| 2026-10-08 | 4,789 | $1.30 | $6,226 |
| 2026-10-02 | 470 | $1.26 | $592 |
| 2026-10-01 | 11 | $1.26 | $14 |
| 2026-09-30 | 14 | $1.31 | $18 |
| 2026-09-28 | 6,197 | $1.36 | $8,428 |
| 2026-09-24 | 3,674 | $1.37 | $5,033 |
| 2026-09-23 | 6,647 | $1.36 | $9,040 |
| 2026-09-21 | 7,013 | $1.39 | $9,748 |
| 2026-09-14 | 2,578 | $1.40 | $3,609 |
| 2026-09-10 | 2,091 | $1.41 | $2,948 |
| 2026-09-04 | 816 | $1.40 | $1,142 |
| 2026-09-02 | 243 | $1.40 | $340 |
| 2026-09-01 | 3,923 | $1.45 | $5,688 |
| 2026-08-28 | 6,642 | $1.46 | $9,697 |
| 2026-08-26 | 2,818 | $1.41 | $3,973 |
| 2026-08-20 | 2,120 | $1.44 | $3,053 |
| 2026-08-18 | 15,738 | $1.65 | $25,968 |
Showing 1–20 of 20 settlements
Key facts
CIK
1736243
CUSIP
00510M203
13F (30d)
10 filings
10 filers
Visit website
Investor relations